Blog

Personalized pain management

There is an urgent need to identify reliable predictors of opioid responses to develop personalized opioid therapy for chronic pain management.


Study links Celebrex, heart valve calcification after earlier research declared drug safe

A well-known, four-year study found popular arthritis drug Celebrex no more dangerous for the heart than older drugs in its same classification – commonly called NSAIDs.


Vanderbilt collaboration yields promising compound to treat arrhythmia

A collaboration between Vanderbilt University professors of chemistry and medicine yielded a promising compound to treat arrhythmia from an unlikely place: the fungal natural product verticilide.


Vanderbilt scientists report new modeling of brain signaling

The release of neurotransmitters and hormones in the body is tightly controlled by complex protein machinery embedded in cell membranes.


Discovery points to new cancer immunotherapy option

An international team involving Vanderbilt researchers has discovered that a new “checkpoint” protein on immune system cells is active in tumors, and that blocking it — in combination with other treatments — is a successful therapeutic approach in mouse models of cancer.


Adhesion protein optimizes border

The epithelial cells that line the intestines build a specialized cell surface — the “brush border” — that processes and absorbs nutrients, and defends against pathogens.


Gene identified that increases risk of antibiotic reaction

Researchers at Vanderbilt University Medical Center and colleagues have identified a gene that increases the risk for a severe and potentially life-threatening reaction to the commonly prescribed antibiotic vancomycin.